Member Communications

The Dose

The Dose is PAMED’s member-exclusive weekly e-newsletter, delivered to your inbox every Thursday. It’s a simple way to get a healthy dose of the hot topics in Pennsylvania medicine.

Each week, you’ll find news and analysis on topics like:

  • New health care laws and regulations
  • State licensure requirements & CME opportunities
  • Reimbursement and payer news, including MACRA-MIPS
  • Pennsylvania court cases that could impact physicians
  • How PAMED is advocating in the legislature on behalf of physicians – on issues like prior authorization, telemedicine, and scope of practice

Latest News Stories

  • Nationwide Pfizer Recall and Subsequent Stockout of Penicillin G Benzathine

    The Pennsylvania Department of Health (DOH) was notified by the Centers for Disease Control and Prevention (CDC) and Pfizer Pharmaceuticals that there is a nationwide voluntary recall and subsequent near-term stockout of Benzathine Penicillin G (Bicillin L-A®)
    Oct 10, 2025

  • The PAMPAC Pulse - March 2024

    A message from the PAMPAC's Chair...
    Oct 10, 2025

  • Rethinking Risk Adjustment

    Stay out of harm’s way when it comes to risk adjustment compliance. Granite GRC Consulting presents a series of monthly articles for the Pennsylvania Medical Society’s DOSE newsletter. This is the first in the series.
    Oct 10, 2025

  • ACIP Voted on Key Vaccine Recommendations

    The Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention held a series of meetings to determine new recommendations that could significantly impact vaccine protocols.
    Oct 10, 2025

  • PAMED Argues for Fairness in Allocation of Damage Awards

    On August 20, 2025, PAMED joined the Pennsylvania Coalition for Civil Justice Reform (PCCJR) and 16 other concerned organizations in the filing of an amicus brief arguing to maintain fairness in the allocation of lawsuit judgment awards.
    Oct 10, 2025

  • Department of Health Renal Disease Advisory Committee Meeting

    The Renal Disease Advisory Committee established by the Renal Disease Treatment Act will hold its quarterly public meeting on Friday, April 19, 2024, from 10 a.m. to 12 p.m.
    Oct 10, 2025